{"transactions":[{"id":868357,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-03-03T23:07:42.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":11.52,"expiration_date":"2036-02-27","underlying":"Common Shares","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001798876-26-000004","document":"wk-form4_1772579259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000179887626000004/wk-form4_1772579259.xml","form_type":"4"}},{"id":944795,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Share Unit Award","published_at":"2026-01-08T02:32:04.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 19,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":9500,"derivative":{"underlying":"Common Shares","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001798876-26-000002","document":"wk-form4_1767839521.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000179887626000002/wk-form4_1767839521.xml","form_type":"4"}},{"id":944794,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2026-01-08T02:32:04.000Z","date":"2026-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2381,"price":9.93,"value":23643.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025."}],"balance_after":7715,"source":{"system":"sec-edgar","filing":"0001798876-26-000002","document":"wk-form4_1767839521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000179887626000002/wk-form4_1767839521.xml","form_type":"4"}},{"id":944793,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2026-01-08T02:32:04.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025."}],"balance_after":10096,"source":{"system":"sec-edgar","filing":"0001798876-26-000002","document":"wk-form4_1767839521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000179887626000002/wk-form4_1767839521.xml","form_type":"4"}},{"id":1308355,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:51:26.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 19,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":14250,"derivative":{"underlying":"Common Shares","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001935979-25-000006","document":"wk-form4_1736301080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000006/wk-form4_1736301080.xml","form_type":"4"}},{"id":1308354,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:51:26.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 19,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":19000,"derivative":{"underlying":"Common Shares","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001935979-25-000006","document":"wk-form4_1736301080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000006/wk-form4_1736301080.xml","form_type":"4"}},{"id":1308353,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-08T01:51:26.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":112000,"derivative":{"exercise_price":38.64,"expiration_date":"2035-01-05","underlying":"Common Shares","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001935979-25-000006","document":"wk-form4_1736301080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000006/wk-form4_1736301080.xml","form_type":"4"}},{"id":1308352,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2025-01-08T01:51:26.000Z","date":"2025-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2331,"price":38.64,"value":90069.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."}],"balance_after":4802,"source":{"system":"sec-edgar","filing":"0001935979-25-000006","document":"wk-form4_1736301080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000006/wk-form4_1736301080.xml","form_type":"4"}},{"id":1308351,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2025-01-08T01:51:26.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":true,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7133,"source":{"system":"sec-edgar","filing":"0001935979-25-000006","document":"wk-form4_1736301080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000006/wk-form4_1736301080.xml","form_type":"4"}},{"id":1473477,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2024-06-20T11:30:00.000Z","date":"2024-06-17","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":33.583,"value":1007490.0,"ownership":{"direct":false,"nature":"By IRA"},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001562180-24-005174","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024005174/primarydocument.xml","form_type":"4"}},{"id":1688402,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-01-05T01:08:02.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":96250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on January 2, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":96250,"derivative":{"exercise_price":41.93,"expiration_date":"2034-01-02","underlying":"Common Shares","underlying_shares":96250},"source":{"system":"sec-edgar","filing":"0001562180-24-000286","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024000286/primarydocument.xml","form_type":"4"}},{"id":1748805,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-11-07T01:32:10.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":78750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on November 2, 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":78750,"derivative":{"exercise_price":29.49,"expiration_date":"2033-11-02","underlying":"Common Shares","underlying_shares":78750},"source":{"system":"sec-edgar","filing":"0001562180-23-007576","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218023007576/primarydocument.xml","form_type":"4"}},{"id":2142534,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:40:53.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":7,"expiration_date":"2032-10-04","underlying":"Common Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001562180-22-007083","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007083/primarydocument.xml","form_type":"4"}},{"id":2353911,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock options (right to buy)","published_at":"2022-03-03T21:11:46.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 1, 2022. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":41000,"derivative":{"exercise_price":32.2,"expiration_date":"2032-03-01","underlying":"Common stock","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001439222-22-000030","document":"wf-form4_164634187837787.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000030/wf-form4_164634187837787.xml","form_type":"4"}},{"id":2353910,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted stock units","published_at":"2022-03-03T21:11:46.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on  March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on  March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":11500,"derivative":{"underlying":"Common stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001439222-22-000030","document":"wf-form4_164634187837787.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000030/wf-form4_164634187837787.xml","form_type":"4"}},{"id":2378321,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance share units","published_at":"2022-02-23T21:11:14.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":6874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified regulatory milestone was determined to have been met on February 18, 2022, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified regulatory milestone was determined to have been met on February 18, 2022, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":6874,"derivative":{"underlying":"Common stock","underlying_shares":6874},"source":{"system":"sec-edgar","filing":"0001439222-22-000019","document":"wf-form4_164565065647827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000019/wf-form4_164565065647827.xml","form_type":"4"}},{"id":2378320,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2022-02-23T21:11:14.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":2041,"price":29.08,"value":59352.28,"ownership":{"direct":true},"balance_after":16752,"source":{"system":"sec-edgar","filing":"0001439222-22-000019","document":"wf-form4_164565065647827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000019/wf-form4_164565065647827.xml","form_type":"4"}},{"id":2378319,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2022-02-23T21:11:14.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":6874,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18793,"source":{"system":"sec-edgar","filing":"0001439222-22-000019","document":"wf-form4_164565065647827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000019/wf-form4_164565065647827.xml","form_type":"4"}},{"id":2397747,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted stock units","published_at":"2022-02-14T21:07:33.000Z","date":"2022-02-10","kind":"exercise","acquired":false,"shares":3667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":7333,"derivative":{"underlying":"Common stock","underlying_shares":3667},"source":{"system":"sec-edgar","filing":"0001439222-22-000005","document":"wf-form4_164487282368778.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000005/wf-form4_164487282368778.xml","form_type":"4"}},{"id":2397746,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2022-02-14T21:07:33.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":1073,"price":31.425,"value":33719.025,"ownership":{"direct":true},"balance_after":11919,"source":{"system":"sec-edgar","filing":"0001439222-22-000005","document":"wf-form4_164487282368778.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000005/wf-form4_164487282368778.xml","form_type":"4"}},{"id":2397745,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2022-02-14T21:07:33.000Z","date":"2022-02-10","kind":"exercise","acquired":true,"shares":3667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":12992,"source":{"system":"sec-edgar","filing":"0001439222-22-000005","document":"wf-form4_164487282368778.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000005/wf-form4_164487282368778.xml","form_type":"4"}},{"id":2438838,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted stock units","published_at":"2022-01-10T21:06:35.000Z","date":"2022-01-06","kind":"exercise","acquired":false,"shares":3437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 6, 2020. Beginning on January 6, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 6, 2020. Beginning on January 6, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":3437,"derivative":{"underlying":"Common stock","underlying_shares":3437},"source":{"system":"sec-edgar","filing":"0001439222-22-000001","document":"wf-form4_164184875990924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000001/wf-form4_164184875990924.xml","form_type":"4"}},{"id":2438837,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2022-01-10T21:06:35.000Z","date":"2022-01-06","kind":"tax_withholding","acquired":false,"shares":1205,"price":32.5801,"value":39259.0205,"ownership":{"direct":true},"balance_after":9325,"source":{"system":"sec-edgar","filing":"0001439222-22-000001","document":"wf-form4_164184875990924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000001/wf-form4_164184875990924.xml","form_type":"4"}},{"id":2438836,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2022-01-10T21:06:35.000Z","date":"2022-01-06","kind":"exercise","acquired":true,"shares":3437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":10530,"source":{"system":"sec-edgar","filing":"0001439222-22-000001","document":"wf-form4_164184875990924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000001/wf-form4_164184875990924.xml","form_type":"4"}},{"id":2748523,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted stock units","published_at":"2021-04-15T20:46:36.000Z","date":"2021-01-06","kind":"exercise","acquired":false,"shares":3437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 6, 2020. Beginning on January 6, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 6, 2020. Beginning on January 6, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":6874,"derivative":{"underlying":"Common stock","underlying_shares":3437},"source":{"system":"sec-edgar","filing":"0001439222-21-000033","document":"wf-form4_161851957884956.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000033/wf-form4_161851957884956.xml","form_type":"4"}},{"id":2748522,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-04-15T20:46:36.000Z","date":"2021-01-06","kind":"tax_withholding","acquired":false,"shares":1191,"price":44.0859,"value":52506.3069,"ownership":{"direct":true},"balance_after":7093,"source":{"system":"sec-edgar","filing":"0001439222-21-000033","document":"wf-form4_161851957884956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000033/wf-form4_161851957884956.xml","form_type":"4"}},{"id":2748521,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-04-15T20:46:36.000Z","date":"2021-01-06","kind":"exercise","acquired":true,"shares":3437,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8284,"source":{"system":"sec-edgar","filing":"0001439222-21-000033","document":"wf-form4_161851957884956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000033/wf-form4_161851957884956.xml","form_type":"4"}},{"id":2863119,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-02-12T21:23:25.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":44000,"derivative":{"exercise_price":56.68,"expiration_date":"2031-02-10","underlying":"Common stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001439222-21-000006","document":"wf-form4_161316498183368.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000006/wf-form4_161316498183368.xml","form_type":"4"}},{"id":2863118,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted stock units","published_at":"2021-02-12T21:23:25.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":11000,"derivative":{"underlying":"Common stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001439222-21-000006","document":"wf-form4_161316498183368.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000006/wf-form4_161316498183368.xml","form_type":"4"}},{"id":3176457,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance share units","published_at":"2020-04-15T20:25:57.000Z","date":"2020-04-13","kind":"exercise","acquired":false,"shares":6874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service.  The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date.  Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service.  The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date.  Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":13748,"derivative":{"underlying":"Common stock","underlying_shares":6874},"source":{"system":"sec-edgar","filing":"0001439222-20-000029","document":"wf-form4_158698234017383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/wf-form4_158698234017383.xml","form_type":"4"}},{"id":3176456,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2020-04-15T20:25:57.000Z","date":"2020-04-14","kind":"tax_withholding","acquired":false,"shares":2027,"price":40.64,"value":82377.28,"ownership":{"direct":true},"balance_after":4847,"source":{"system":"sec-edgar","filing":"0001439222-20-000029","document":"wf-form4_158698234017383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/wf-form4_158698234017383.xml","form_type":"4"}},{"id":3176455,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2020-04-15T20:25:57.000Z","date":"2020-04-13","kind":"exercise","acquired":true,"shares":6874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":6874,"source":{"system":"sec-edgar","filing":"0001439222-20-000029","document":"wf-form4_158698234017383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/wf-form4_158698234017383.xml","form_type":"4"}},{"id":3315210,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted stock units","published_at":"2020-01-08T21:24:51.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":10311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on January 6, 2020. Beginning on January 6, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on January 6, 2020. Beginning on January 6, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":10311,"derivative":{"underlying":"Common stock","underlying_shares":10311},"source":{"system":"sec-edgar","filing":"0001439222-20-000003","document":"wf-form4_157851867389419.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000003/wf-form4_157851867389419.xml","form_type":"4"}},{"id":3315209,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-01-08T21:24:51.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":47007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 6, 2020. The shares underlying this option vest as to 25% of the underlying shares on January 6, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":47007,"derivative":{"exercise_price":48.49,"expiration_date":"2030-01-06","underlying":"Common stock","underlying_shares":47007},"source":{"system":"sec-edgar","filing":"0001439222-20-000003","document":"wf-form4_157851867389419.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000003/wf-form4_157851867389419.xml","form_type":"4"}}]}